We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Carlisle Companies
CSL
$13.5B
| $14M | 0.03% |
131,873
+8,086
| +7% | +$867K |
|
527
Arrow Electronics
ARW
$10.5B
| $14M | 0.03% |
190,624
+5,479
| +3% | +$401K |
|
528
Jefferies Financial Group
JEF
$12.7B
| $14M | 0.03% |
600,463
+3,096
| +0.5% | +$69.2K |
|
529
Kohl's
KSS
$2.16B
| $13.9M | 0.03% |
349,954
-21,808
| -6% | -$890K |
|
530
Coty
COTY
$2.4B
| $13.9M | 0.03% |
764,683
+43,263
| +6% | +$818K |
|
531
Donaldson
DCI
$10.7B
| $13.9M | 0.03% |
304,355
+46,178
| +18% | +$2M |
|
532
Nordson
NDSN
$16.4B
| $13.8M | 0.03% |
112,453
+4,395
| +4% | +$521K |
|
533
Gentex
GNTX
$5.1B
| $13.8M | 0.03% |
646,789
+18,355
| +3% | +$385K |
|
534
Wabtec
WAB
$49.3B
| $13.8M | 0.03% |
176,720
-15,692
| -8% | -$1.3M |
|
|
WCG
535
DELISTED
Wellcare Health Plans, Inc.
WCG
| $13.8M | 0.03% |
98,128
+3,111
| +3% | +$443K |
|
536
Thomson Reuters
TRI
$46.4B
| $13.7M | 0.03% |
273,548
+13,692
| +5% | +$699K |
|
537
Leidos
LDOS
$14.4B
| $13.6M | 0.03% |
266,498
+7,090
| +3% | +$365K |
|
|
AIV
538
Aimco
AIV
$377M
| $13.5M | 0.03% |
2,283,660
+146,233
| +7% | +$872K |
|
539
Copart
CPRT
$28.5B
| $13.4M | 0.03% |
1,729,752
+138,192
| +9% | +$1.02M |
|
540
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
| $13.3M | 0.03% |
42,660
+19,035
| +81% | +$5.91M |
|
|
WP
541
DELISTED
Worldpay, Inc.
WP
| $13.3M | 0.03% |
207,382
+10,324
| +5% | +$657K |
|
542
ManpowerGroup
MAN
$2.6B
| $13.3M | 0.03% |
129,536
+2,900
| +2% | +$281K |
|
|
NFX
543
DELISTED
Newfield Exploration
NFX
| $13.2M | 0.03% |
357,379
+14,379
| +4% | +$559K |
|
|
SRCL
544
DELISTED
Stericycle Inc
SRCL
| $13.2M | 0.03% |
158,918
+9,256
| +6% | +$744K |
|
545
Allegion
ALLE
$13.5B
| $13.2M | 0.03% |
173,816
+5,469
| +3% | +$386K |
|
546
Robert Half
RHI
$4.11B
| $13.1M | 0.03% |
269,213
-1,150
| -0.4% | -$55.6K |
|
547
Lennox International
LII
$15B
| $13.1M | 0.03% |
78,506
+2,760
| +4% | +$446K |
|
548
West Pharmaceutical
WST
$23.7B
| $13.1M | 0.03% |
160,677
+4,362
| +3% | +$365K |
|
549
SiriusXM
SIRI
$11B
| $13M | 0.03% |
251,867
+10,170
| +4% | +$500K |
|
|
EVHC
550
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $13M | 0.03% |
211,450
+14,188
| +7% | +$951K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.